Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q4 2019 · 10-K
Revenue$191.66M$191.66M+6.3% vs Q4 2018 Net Income$16.46M$16.46M−60.5% vs Q4 2018 EPS Diluted$0.42$0.42−60.7% vs Q4 2018 Gross Profitderived$128,260,000+5.0% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Incomederived$43,263,000+0.8% Operating Cash Flowderived$55,946,000−13.7% Free Cash Flowderived$44,254,000−25.0% Margins · derivedGross margin66.9%−0.9 pt vs Q4 2018
Operating margin22.6%−1.2 pt vs Q4 2018
Net margin8.6%−14.5 pt vs Q4 2018
ended Jun 30, 2019 · filed Aug 28, 2019 · 59 d after period end